CIK 0001022079
- Large accelerated filer
QUEST DIAGNOSTICS INC
Sign in to watch- Ticker
- DGX
- Exchange
- NYSE
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 161387862
- Phone
- +1 973-520-2700
- Business address
- 500 PLAZA DRIVE, SECAUCUS, NJ, 07094
- Former names
- CORNING CLINICAL LABORATORIES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $19,794,069
- in 6 filings, $19.8M under 10b5-1 plans
Net −$19,794,069. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- PREVOZNIK MICHAEL E −$5.5M SVP & General Counsel sold 38% of stake
- Doherty Catherine T. −$5.5M Executive Vice President sold 24% of stake
- Deppe Michael J −$3.1M SVP, Corp. Controller & CAO sold 25% of stake
- Plewman Patrick −$3.0M SVP for Diagnostic Services sold 44% of stake
- Davis J. E. −$2.4M CEO and President sold 8% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-03-01 | PREVOZNIK MICHAEL E SVP & General Counsel | Grant or award | +6,647 | $86.86 | $577K | 46,100 |
| 2019-03-01 | PREVOZNIK MICHAEL E SVP & General Counsel | Shares withheld for taxes | −3,274 | $86.86 | $284K | 42,826 |
| 2019-03-01 | Klug Robert A VP, Corporate Controller | Grant or award | +1,355 | $86.86 | $118K | 6,648 |
| 2019-03-01 | Klug Robert A VP, Corporate Controller | Shares withheld for taxes | −420 | $86.86 | $36K | 6,261 |
| 2019-03-01 | GUINAN MARK Executive Vice President & CFO | Grant or award | +10,736 | $86.86 | $933K | 71,305 |
| 2019-03-01 | GUINAN MARK Executive Vice President & CFO | Shares withheld for taxes | −5,288 | $86.86 | $459K | 66,017 |
| 2019-03-01 | Doherty Catherine T. SVP, Group Exec. Clin. Fran. | Grant or award | +7,669 | $86.86 | $666K | 77,193 |
| 2019-03-01 | Doherty Catherine T. SVP, Group Exec. Clin. Fran. | Shares withheld for taxes | −3,777 | $86.86 | $328K | 73,416 |
| 2019-03-01 | Davis J. E. EVP, General Diagnostics | Grant or award | +10,225 | $86.86 | $888K | 50,321 |
| 2019-03-01 | Davis J. E. EVP, General Diagnostics | Shares withheld for taxes | −5,839 | $86.86 | $507K | 44,534 |
| 2019-03-01 | Cunningham Everett SVP, Commercial | Grant or award | +7,669 | $86.86 | $666K | 45,928 |
| 2019-03-01 | Cunningham Everett SVP, Commercial | Shares withheld for taxes | −3,777 | $86.86 | $328K | 42,151 |
| 2019-02-27 | PREVOZNIK MICHAEL E SVP & General Counsel | Sale | −1,048 | $86.51 | $91K | 39,453 |
| 2019-02-27 | Cunningham Everett SVP, Commercial | Sale | −1,144 | $86.51 | $99K | 38,259 |
| 2019-02-26 | RUSCKOWSKI STEPHEN H Chairman, President and CEO | Shares withheld for taxes | −6,676 | $87.84 | $586K | 197,406 |
| 2019-02-26 | PREVOZNIK MICHAEL E SVP & General Counsel | Shares withheld for taxes | −907 | $87.84 | $80K | 40,865 |
| 2019-02-26 | PREVOZNIK MICHAEL E SVP & General Counsel | Sale | −364 | $87.06 | $32K | 40,501 |
| 2019-02-26 | Klug Robert A VP, Corporate Controller | Shares withheld for taxes | −142 | $87.84 | $12K | 5,293 |
| 2019-02-26 | GUINAN MARK Executive Vice President & CFO | Shares withheld for taxes | −1,556 | $87.84 | $137K | 60,569 |
| 2019-02-26 | Doherty Catherine T. SVP, Group Exec. Clin. Fran. | Shares withheld for taxes | −1,066 | $87.84 | $94K | 69,524 |
Page 49 of 52 · 1,040 trades